(Q35815973)

10 August 2017

1 reference

title

Topical photodynamic therapy in clinical dermatology (English)

1 reference

10 August 2017

Kormeili T

1

1 reference

10 August 2017

Yamauchi PS

series ordinal

2

1 reference

10 August 2017

Lowe NJ

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

British Journal of Dermatology

10 August 2017

published in

1 reference

10 August 2017

volume

150

1 reference

10 August 2017

issue

6

1 reference

10 August 2017

page(s)

1061-1069

1 reference

Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

The advantages of aminolevulinic acid photodynamic therapy in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Genotoxic potential of porphyrin type photosensitizers with particular emphasis on 5-aminolevulinic acid: implications for clinical photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Laser and non-laser light sources for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Enhanced photodynamic effects using fractionated laser light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Levulan: the first approved topical photosensitizer for the treatment of actinic keratosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Laser-Mediated Photodynamic Therapy of Actinic Keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Photodynamic therapy in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

PpIX fluorescence kinetics and increased skin damage after intracutaneous injection of 5-aminolevulinic acid and repeated illumination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Development of a stable solution of 5-aminolaevulinic acid for intracutaneous injection in photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Systemic photodynamic therapy with aminolevulinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Successful treatment of cutaneous sarcoidosis using topical photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Topical ALA-photodynamic therapy for the treatment of acne vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Epidermodysplasia verruciformis treated using topical 5-aminolaevulinic acid photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Non-oncologic indications for ALA-PDT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Photodynamic photorejuvenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Pain caused by photodynamic therapy of skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.05940.X

10.1111/J.1365-2133.2004.05940.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference